USA Vape Lab Gets Filing Letter From FDA for PMTA
Credit: Naked 100
USA Vape Lab, one of the largest e-liquid manufacturers in the world, announced that it received its filing letter from the U.S. Food and Drug Administration (FDA). The filing letter acknowledges that the company’s premarket tobacco product applications (PMTAs) for their Naked 100 products are sufficiently complete, advancing the brand’s application forward to the substantive review phase.
During the substantive review phase, the FDA evaluates the scientific studies and data presented in the applications submitted to ensure that the products are appropriate for the protection of the public health (APPH).
“We are excited to be advancing further through the PMTA process. Our team has dedicated time and resources to ensure we have the data, research, and necessary components needed for our applications,” said Huy Nguyen, CEO of USA Vape Lab. “We are optimistic that our applications will continue to advance and result in the FDA granting USA Vape Lab with marketing orders.”
The company says it continues to maintain the highest standards of regulatory compliance and is committed to working with the FDA as its applications undergo review.
